Literature DB >> 29931106

Comparison of Alere i Strep A Rapid Molecular Assay With Rapid Antigen Testing and Culture in a Pediatric Outpatient Setting.

Elizabeth P Weinzierl1,2, Robert C Jerris1,2, Mark D Gonzalez1,2, Julie A Piccini1, Beverly B Rogers1,2.   

Abstract

Objectives: Group A Streptococcus (GAS) is the most common bacterial cause of pediatric acute pharyngitis, and its quick identification is important for subsequent treatment. We sought to determine whether molecular GAS-based testing can successfully replace GAS antigen testing and subsequent culture in a pediatric urgent care center.
Methods: We tested 160 patient oropharyngeal samples by a rapid antigen GAS test, the Alere i Strep A test, and throat culture in a pediatric urgent care setting and calculated basic statistical metrics.
Results: The sensitivity and specificity of the molecular test were 98% and 100%, respectively, compared with culture. There was a 9% false-positive rate with the rapid antigen-based testing. Conclusions: The Alere test is sufficiently sensitive and specific for definitive GAS testing in a pediatric urgent care setting. This implementation has enabled us to provide definitive patient results at the time of each patient encounter.

Entities:  

Year:  2018        PMID: 29931106     DOI: 10.1093/ajcp/aqy038

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.

Authors:  Hannah Fraser; Daniel Gallacher; Felix Achana; Rachel Court; Sian Taylor-Phillips; Chidozie Nduka; Chris Stinton; Rebecca Willans; Paramjit Gill; Hema Mistry
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

Review 2.  Group A Streptococcus Testing in Pediatrics: the Move to Point-of-Care Molecular Testing.

Authors:  Thomas Z Thompson; Allison R McMullen
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

3.  Multicenter Clinical Evaluation of the Automated Aries Group A Strep PCR Assay from Throat Swabs.

Authors:  N Kanwar; J Crawford; C Ulen; T S Uphoff; J Dien Bard; R Dunn; A Drain; R Selvarangan
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

4.  Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study.

Authors:  Anna P Ralph; Deborah C Holt; Sharifun Islam; Joshua Osowicki; David E Carroll; Steven Y C Tong; Asha C Bowen
Journal:  Open Forum Infect Dis       Date:  2019-02-26       Impact factor: 3.835

5.  Single-centre, open-label, randomised, trial to compare rapid molecular point-of-care streptococcal testing to standard laboratory-based testing for the management of streptococcal pharyngitis in children: study protocol.

Authors:  Jeffrey M Pernica; Fiona Smaill; April J Kam; Amy Bartholomew; Quynh Doan; Marek Smieja; Sarah Khan; Melani Sung; Lehana Thabane; David M Goldfarb
Journal:  BMJ Open       Date:  2021-08-11       Impact factor: 2.692

Review 6.  Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review.

Authors:  Zahid Mustafa; Masoumeh Ghaffari
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.